Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in which many processes are detected including (neuro)inflammation. Many drugs have been tested for ALS in clinical trials but most have failed to reach their primary endpoints. The development and inclusion of different...

Descripción completa

Detalles Bibliográficos
Autores principales: Staats, Kim A., Borchelt, David R., Tansey, Malú Gámez, Wymer, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785449/
https://www.ncbi.nlm.nih.gov/pubmed/35073950
http://dx.doi.org/10.1186/s13024-022-00515-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785449/
https://www.ncbi.nlm.nih.gov/pubmed/35073950
http://dx.doi.org/10.1186/s13024-022-00515-1

Ejemplares similares